TIGIT and hereditary clear cell renal cell carcinoma: Furthermore, combined treatment of TIGIT and PD-1 mAb had achieved good therapeutic effects in other cancers, such as glioblastoma (19), head and neck squamous cell carcinoma (21) and renal cell carcinoma (36).